StockNews.AI
COO
StockNews.AI
197 days

CooperCompanies Announces Release Date for First Quarter 2025

1. CooperCompanies will report Q1 2025 financial results on March 6. 2. A conference call to discuss results will follow at 5:00 PM ET. 3. CooperCompanies operates globally in medical devices, impacting over 50 million lives.

3m saved
Insight
Article

FAQ

Why Neutral?

The announcement is routine and expected, similar to previous earnings reports.

How important is it?

Earnings reports can influence financial performance but are typical corporate events.

Why Short Term?

Market reaction is likely immediate post-report, reflecting current performance.

Related Companies

February 03, 2025 16:15 ET  | Source: CooperCompanies SAN RAMON, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today announced it will report first quarter 2025 financial results on Thursday, March 6, 2025, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 7466264. A simultaneous audio webcast and subsequent replay can be accessed at http://investor.coopercos.com. About CooperCompaniesCooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life’s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women’s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies has a workforce of more than 16,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit www.coopercos.com. Contact:Kim DuncanVice President, Investor Relations and Risk Management925-460-3663ir@cooperco.com

Related News